Monitoring and evaluation of COVID-19 response in the WHO African region: challenges and lessons learned.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
14 04 2021
Historique:
pubmed: 15 4 2021
medline: 15 1 2022
entrez: 14 4 2021
Statut: epublish

Résumé

Monitoring and evaluation (M&E) is an essential component of public health emergency response. In the WHO African region (WHO AFRO), over 100 events are detected and responded to annually. Here we discuss the development of the M&E for COVID-19 that established a set of regional and country indicators for tracking the COVID-19 pandemic and response measures. An interdisciplinary task force used the 11 pillars of strategic preparedness and response to define a set of inputs, outputs, outcomes and impact indicators that were used to closely monitor and evaluate progress in the evolving COVID-19 response, with each pillar tailored to specific country needs. M&E data were submitted electronically and informed country profiles, detailed epidemiological reports, and situation reports. Further, 10 selected key performance indicators were tracked to monitor country progress through a bi-weekly progress scoring tool used to identify priority countries in need of additional support from WHO AFRO. Investment in M&E of health emergencies should be an integral part of efforts to strengthen national, regional and global capacities for early detection and response to threats to public health security. The development of an adaptable M&E framework for health emergencies must draw from the lessons learned throughout the COVID-19 response.

Identifiants

pubmed: 33849676
doi: 10.1017/S0950268821000807
pii: S0950268821000807
pmc: PMC8723986
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e98

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Références

Lancet Digit Health. 2020 Oct;2(10):e500-e502
pubmed: 32838251
Emerg Infect Dis. 2020 Nov;26(11):2555-2564
pubmed: 33079032

Auteurs

Benido Impouma (B)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.
Institute of Global Health, University of Geneva, Geneva, Switzerland.

Caitlin M Wolfe (CM)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.
College of Public Health, University of South Florida, Tampa, Florida, USA.

Franck Mboussou (F)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Bridget Farham (B)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Tessa Saturday (T)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Cyril Pervilhac (C)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Nsarhaza Bishikwabo (N)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Tamayi Mlanda (T)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Arish Bukhari Muhammad (AB)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Fleury Moussana (F)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Ambrose Talisuna (A)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Humphrey Karamagi (H)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Olivia Keiser (O)

Institute of Global Health, University of Geneva, Geneva, Switzerland.

Antoine Flahault (A)

Institute of Global Health, University of Geneva, Geneva, Switzerland.

Joseph Cabore (J)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Matshidiso Moeti (M)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH